6007

SHH:600771

GuangYuYuan Chinese Herbal Medicine Co., Ltd.

  • Stock

CNY

Last Close

20.97

08/11 07:00

Market Cap

8.93B

Beta: 0.56

Volume Today

20.16M

Avg: 12.28M

PE Ratio

−33.46

PFCF: −30.64

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
62.21M
-
60.30M
3.07%
81.55M
35.23%
97.43M
19.48%
141.87M
45.61%
277.86M
95.85%
448.84M
61.54%
443.49M
1.19%
357.78M
19.33%
382.71M
6.97%
average payables
73.36M
-
67.53M
7.95%
80.55M
19.28%
93.54M
16.13%
135.32M
44.66%
205.35M
51.75%
459.82M
123.93%
732.70M
59.34%
637.21M
13.03%
388.39M
39.05%
average receivables
541.14M
-
313.51M
42.07%
271.08M
13.53%
497.84M
83.65%
900.53M
80.89%
1.37B
52.56%
1.74B
26.71%
1.93B
10.79%
1.83B
5.17%
1.36B
25.64%
book value per share
0.14
-
0.25
77.39%
2.52
922.98%
4.37
73.78%
3.87
11.53%
6.48
67.58%
4.71
27.31%
5.28
11.98%
4.25
19.47%
3.46
18.63%
capex per share
-0.12
-
-0.03
75.23%
-0.27
823.41%
-0.45
63.94%
-0.58
29.54%
-0.57
1.52%
-0.17
69.25%
-0.11
37.82%
-0.04
66.09%
-0.02
52.19%
capex to depreciation
-4.19
-
-2.12
49.29%
-15.87
646.98%
-24.96
57.33%
-37.51
50.26%
-15.25
59.36%
-2.73
82.09%
-1.43
47.58%
-0.47
66.89%
-0.22
53.42%
capex to operating cash flow
2.16
-
0.22
89.69%
1.29
476.72%
0.82
36.14%
1.55
89.14%
0.67
56.70%
0.62
7.78%
0.66
5.96%
-0.22
134.02%
-0.03
84.71%
capex to revenue
-0.15
-
-0.03
81.27%
-0.18
534.34%
-0.19
3.05%
-0.24
31.51%
-0.12
49.29%
-0.07
42.03%
-0.04
37.66%
-0.02
52.40%
-0.01
59.10%
cash per share
0.10
-
0.11
1.94%
1.75
1,541.42%
2.44
39.35%
0.55
77.68%
0.31
42.93%
0.45
44.73%
0.84
86.47%
0.28
66.93%
0.50
80.21%
days of inventory on hand
170.36
-
291.00
70.81%
292.49
0.51%
179.06
38.78%
323.40
80.61%
445.80
37.85%
707.83
58.78%
414.96
41.38%
388.58
6.36%
436.63
12.36%
days payables outstanding
205.52
-
307.45
49.59%
273.94
10.90%
175.79
35.83%
303.44
72.62%
286.08
5.72%
918.07
220.92%
898.58
2.12%
538.53
40.07%
304.52
43.45%
days sales outstanding
486.86
-
277.64
42.97%
232.38
16.30%
281.61
21.19%
336.72
19.57%
376.45
11.80%
543.41
44.35%
672.89
23.83%
688.99
2.39%
406.41
41.01%
debt to assets
0.03
-
0.08
231.70%
0.02
74.52%
0.02
9.87%
0.04
126.52%
0.07
48.96%
0.05
20.84%
0.09
71.61%
0.11
19.52%
0.16
50.63%
debt to equity
0.28
-
0.46
64.44%
0.03
93.08%
0.02
24.19%
0.06
137.54%
0.09
52.41%
0.08
11.73%
0.14
80.04%
0.16
12.18%
0.25
62.91%
dividend yield
0.00
-
0.00
15.19%
0.00
208.31%
0.00
92.98%
0.00
27.87%
0.00
3,427.62%
0.00
62.42%
0.00
7.74%
0.00
46.79%
0.00
67.95%
earnings yield
-0.00
-
0.01
306.34%
0.00
95.10%
0.01
4,107.89%
0.02
24.47%
0.05
235.60%
0.02
72.11%
0.00
69.42%
-0.02
433.23%
-0.03
95.30%
enterprise value
6.30B
-
5.74B
8.84%
6.01B
4.72%
8.41B
39.82%
14.29B
69.97%
6.87B
51.90%
8.42B
22.50%
6.77B
19.62%
21.46B
217.09%
13.88B
35.32%
enterprise value over ebitda
412.68
-
85.78
79.21%
184.52
115.13%
40.85
77.86%
44.72
9.47%
13.35
70.15%
30.79
130.67%
47.15
53.13%
-67.84
243.88%
-47.30
30.27%
ev to operating cash flow
-335.08
-
-127.30
62.01%
-100.19
21.30%
-39.69
60.38%
-77.79
95.98%
-23.07
70.35%
-59.79
159.21%
-89.61
49.88%
263.74
394.31%
54.77
79.23%
ev to sales
23.49
-
16.21
30.99%
14.03
13.43%
8.97
36.07%
12.23
36.27%
4.25
65.27%
6.92
62.93%
6.10
11.82%
25.12
311.82%
13.96
44.45%
free cash flow per share
-0.17
-
-0.16
7.12%
-0.48
199.31%
-0.99
104.53%
-0.95
3.98%
-1.41
48.99%
-0.46
67.70%
-0.27
39.98%
0.13
146.70%
0.50
288.92%
free cash flow yield
-0.01
-
-0.01
2.21%
-0.02
119.85%
-0.04
95.60%
-0.03
21.51%
-0.07
125.74%
-0.03
63.27%
-0.02
31.81%
0.00
116.19%
0.02
501.97%
graham net net
-0.36
-
-0.30
15.96%
1.48
590.51%
2.90
96.20%
1.28
55.99%
2.34
83.19%
1.50
35.86%
1.69
12.35%
1.14
32.63%
0.58
48.57%
graham number
0.42
-
0.77
82.37%
0.64
17.42%
5.56
774.43%
6.45
16.07%
12.43
92.66%
5.25
57.78%
2.88
45.09%
8.02
178.20%
8.13
1.32%
income quality
0.74
-
-1.78
340.83%
-6.43
261.09%
-1.38
78.61%
-0.73
46.68%
-0.76
3.05%
-1.03
35.59%
-2.55
149.05%
-0.24
90.41%
-0.61
147.78%
intangibles to total assets
0.05
-
0.02
64.66%
0.01
53.20%
0.01
42.57%
0.04
217.07%
0.03
18.46%
0.03
12.50%
0.03
4.87%
0.03
22.47%
0.04
11.74%
interest coverage
-9.61
-
-0.88
90.84%
3.56
504.90%
59.63
1,573.27%
52.50
11.97%
30.62
41.68%
7.02
77.07%
3.63
48.28%
-12.32
439.28%
-13.20
7.13%
interest debt per share
0.06
-
0.13
123.20%
0.10
27.22%
0.11
18.55%
0.23
105.43%
0.61
161.79%
0.43
29.03%
0.80
84.75%
0.72
9.42%
0.93
28.59%
inventory turnover
2.14
-
1.25
41.46%
1.25
0.51%
2.04
63.35%
1.13
44.63%
0.82
27.46%
0.52
37.02%
0.88
70.58%
0.94
6.79%
0.84
11.00%
invested capital
0.28
-
0.46
64.44%
0.03
93.08%
0.02
24.19%
0.06
137.54%
0.09
52.41%
0.08
11.73%
0.14
80.04%
0.16
12.18%
0.25
62.91%
market cap
6.32B
-
5.74B
9.22%
6.49B
13.14%
9.33B
43.75%
14.46B
54.92%
6.81B
52.93%
8.48B
24.65%
6.83B
19.55%
21.28B
211.72%
13.69B
35.64%
net current asset value
-116.72M
-
-606.71K
99.48%
541.01M
89,272.24%
1.38B
155.39%
1.31B
5.08%
1.45B
10.57%
1.49B
2.84%
1.48B
0.55%
1.16B
21.55%
787.13M
32.34%
net debt to ebitda
-1.54
-
0.03
102.21%
-14.75
43,482.86%
-4.51
69.46%
-0.54
88.12%
0.13
124.10%
-0.24
284.09%
-0.40
69.85%
-0.58
43.26%
-0.64
10.05%
net income per share
-0.06
-
0.11
287.50%
0.01
93.33%
0.31
4,300.00%
0.48
52.27%
1.06
121.49%
0.26
75.47%
0.07
73.08%
-0.67
1,061.08%
-0.85
26.18%
operating cash flow per share
-0.05
-
-0.13
140.17%
-0.21
60.12%
-0.54
156.73%
-0.37
31.51%
-0.84
127.45%
-0.28
66.66%
-0.17
41.31%
0.16
199.68%
0.51
212.64%
payables turnover
1.78
-
1.19
33.15%
1.33
12.23%
2.08
55.84%
1.20
42.07%
1.28
6.07%
0.40
68.84%
0.41
2.17%
0.68
66.86%
1.20
76.85%
receivables turnover
0.75
-
1.31
75.36%
1.57
19.48%
1.30
17.48%
1.08
16.37%
0.97
10.55%
0.67
30.72%
0.54
19.24%
0.53
2.34%
0.90
69.53%
research and ddevelopement to revenue
0.01
-
0.00
69.10%
0.01
82.03%
0.00
39.85%
0.03
578.28%
0.04
34.96%
0.05
42.71%
0.04
24.00%
0.03
24.68%
0.03
1.28%
return on tangible assets
-0.04
-
0.08
305.89%
0.00
97.62%
0.06
2,921.51%
0.10
68.68%
0.13
28.22%
0.04
69.86%
0.01
77.12%
-0.11
1,379.42%
-0.16
43.96%
revenue per share
0.78
-
1.04
32.22%
1.51
45.57%
2.40
59.09%
2.36
1.50%
4.59
94.20%
2.43
46.96%
2.43
0.26%
1.73
28.76%
2.02
16.89%
roe
-0.41
-
0.44
205.70%
0.00
99.35%
0.07
2,431.94%
0.12
72.11%
0.16
32.17%
0.06
66.26%
0.01
75.96%
-0.16
1,293.48%
-0.25
55.07%
roic
-1.12
-
-0.03
97.18%
0.01
129.22%
0.08
815.74%
0.11
35.27%
0.16
41.12%
0.08
48.48%
0.07
19.06%
-0.14
316.22%
-0.16
9.42%
sales general and administrative to revenue
0.10
-
0.10
2.02%
0.09
14.99%
0.05
38.21%
0.05
17.23%
0.03
43.53%
0.03
34.19%
0.03
0.10%
0.04
15.38%
0.03
31.86%
shareholders equity per share
0.14
-
0.25
77.39%
2.52
922.98%
4.37
73.78%
3.87
11.53%
6.48
67.58%
4.71
27.31%
5.28
11.98%
4.25
19.47%
3.46
18.63%
stock based compensation to revenue
tangible asset value
46.20M
-
77.13M
66.94%
727.93M
843.82%
1.70B
133.94%
1.88B
10.51%
2.26B
20.00%
2.34B
3.77%
2.37B
1.10%
2.04B
13.88%
1.63B
20.33%
tangible book value per share
0.13
-
0.23
67.10%
2.56
1,035.71%
4.36
70.17%
3.80
12.73%
6.40
68.24%
4.68
26.79%
5.18
10.63%
4.13
20.32%
3.30
20.03%
working capital
-53.57M
-
10.34M
119.30%
551.64M
5,234.71%
1.39B
152.43%
1.34B
3.43%
1.49B
10.52%
1.53B
3.00%
1.54B
0.56%
1.25B
18.69%
1.01B
19.52%

All numbers in CNY (except ratios and percentages)